F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to administer a resident's (R1) scheduled medication for
neuropathic pain and failed to document physician notification of a resident (R1) missing scheduled doses
of the neuropathic pain medication when reviewed for quality of care/treatment in the sample of 3 residents
(R1, R2 and R3). This failure resulted in R1 experiencing increased neuropathic pain to bilateral lower
extremities for 3 days and causing R1 to not consistently sleep for 2 nights due to increased nerve
pain.Findings Include:
Residents Affected - Few
On 8/20/2025 at 1:26 pm, V4 (LPN) stated that if a medication has not been received from the pharmacy,
the nurse should call V2 (Director of Nursing), and the V2 will request that the nurse tell the pharmacy the
medication is needed stat.
On 8/20/2025 at 3:17 pm, V7 (Assistant Director of Nursing) stated that because staff is at the facility to
assist the residents, the nurses know when a resident's multidose blister card gets low, and the nurse
should be calling the doctor for a refill. V7 stated that nurses should follow up with the pharmacy first; if a
new script is needed, the nurse should inform the doctor. V7 stated that if the doctor is not reachable, the
nurse should call the nurse practitioner. V7 stated that if the nurse practitioner is not reachable, the nurse
must contact the medical director. V7 stated that if the doctor has not contacted the nurse back the end of
the nurse's shift, the next shift nurse should follow up by reaching out to the doctor again for the medication
order.
R1's Care Plan (initiated on 11/7/2023, revised on 8/5/2025) documents, in part, a focus of R1 is at
increased risk for alteration in pain/discomfort related to paraplegia due to history of a gun shoot wound
and interventions of administer analgesic medication as ordered per plan of care and assess physical as
well as, psychosomatic reasons for the pain. Recognize that psychosomatic pain may cause physical
distress.
R1's Care Plan (initiated 11/7/2023, revised 6/25/2025) documents, in part, a focus of R1 demonstrating
physical and emotional impairment secondary to neurological damage caused by neuropathy and spinal
cord injury.
Facility's policy titled Medication Administration undated documents, in part, Purpose: To ensure that
resident medications are administered in a timely manner and documentation is completed to substantiate
administration. Policy: Unless otherwise specified by the physician, medications will be administered within
60 minutes before or after the facility's dosing schedule, except before or after meal orders and non-routine
time ordered medications.
Facility's policy titled Ordering Medications dated May 2024 documents, in part, that Refill
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 5
Event ID:
145343
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145343
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/21/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Ambassador Nursing & Rehab Center
4900 North Bernard
Chicago, IL 60625
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Actual harm
Residents Affected - Few
requests can be faxed the pharmacy's main fax number, sent via EHR (Electronic Health Record) system,
reordered via (electronic link format), and/or left on the pharmacy refill voicemail. Refill requests should be
sent in 72 hours prior to the last dose.
Facility's policy titled Guidelines For Pain Management undated documents, Purpose: It is the intent of the
facility to promote resident independency, comfort, and to preserve resident dignity in an ongoing effort to
promote the highest level of quality for their lives. One aspect of this commitment is to maintain an effective
pain management plant to provide residents the means to receive necessary comfort, exercise greater
independence, and therefore enhance their overall welfare and well-being. This policy also documents, in
part, that with chronic pain, many residents may have conditions which cause them to experience chronic
pain; principles of treating chronic pain include pain medication is usually more successful for attaining pain
relief if given routinely, not PRN. The resident's plan of care must be specific for each resident related to
their pain and the management plan in place for pain relief and comfort which include interventions of any
ordered medications. Lastly, this policy documents, PAIN is 'whatever the experiencing person says it is,
existing whenever the experiencing person says it does.
Facility's Job Descriptions for Registered Nurse (RN) and Licensed Practical Nurse (LPN) (both undated)
document, in part, that for the nursing responsibility for drug administration, RN's and LPN's ensure that an
adequate supply of floor stock medications, supplies, and equipment is on hand to meet the nursing needs
of the resident and reports needs to the Nurse Supervisor, and orders prescribed medications, supplies
and equipment as necessary, and in accordance with established policies.
Findings Include:
R1's admission Record documents, in part, diagnoses of paraplegia, polyneuropathy, chronic pain
syndrome, hyperlipidemia, neuromuscular dysfunction of bladder, insomnia, acquired absence of kidney,
puncture wound of abdomen, assault by other firearm discharge, need for assistance with personal care,
resistance to multiple antibiotics, dependence on wheelchair, and constipation.
R1's Minimum Data Set (MDS), dated [DATE], documents, in part, a Brief Interview for Mental Status
(BIMS) score of 15 which indicates that R1 is cognitively intact.
On 8/20/2025 at 1:34 PM, R1 observed propelling self with R1's arms while in R1's manual wheelchair. R1
stated that R1 has paraplegia and neuropathy with R1 experiencing pain up and down my (R1's) legs but
it's primarily in my left knee, right thigh and right foot. R1 stated, The pain is burning, tightness and sharp.
It's like a shooting pain. It's real bad when it's in my foot and shoots up my leg. It's a lot of pain. R1 stated
that R1 uses a massager to help with this neuropathic pain since it's on and off all day; however, the
massager doesn't make the pain go away, just slows down the hurting. R1 stated that R1 has scheduled
medication for the neuropathy pain which is Pregabalin 200 milligrams (mg) three times a day. R1 stated
that R1 does have an order for Hydrocodone/Acetaminophen, but Hydrocodone doesn't help with my
neuropathy pain if I am not getting my scheduled Pregabalin. R1 stated that R1 received 2 doses of
Hydrocodone/Acetaminophen over this past weekend (8/15/2025 to 8/17/2025) when the facility did not
administer R1's Pregabalin, but it (Hydrocodone/Acetaminophen) didn't work. R1 stated, I couldn't sleep all
Saturday (8/16/2025) and Sunday (8/17/2025) nights. I stayed up all night with shooting pain. I couldn't go
to sleep. I finally felt relief when I got it (Pregabalin) on Monday (8/18). R1 stated that on Wednesday,
8/13/2025, around 7:00 AM, R1 near V4 (Licensed Practical Nurse, LPN) and V9 (LPN) hearing V9 saying
to V4 that they put in another order because I only have 2 days left of my medication, the Pregabalin. R1
stated that the Pregabalin must not
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145343
If continuation sheet
Page 2 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145343
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/21/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Ambassador Nursing & Rehab Center
4900 North Bernard
Chicago, IL 60625
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Actual harm
Residents Affected - Few
have been reordered because R1 took the last dose of Pregabalin on 8/15/2025 at 1:00 PM. R1 stated that
V14 (LPN) administered R1's Baclofen on 8/15/2025 at 9:00 PM, but not dose of Pregabalin 200 mg. R1
stated that on the night of 8/15/2025, R1 had severe nerve pain and asked for a Hydrocodone 5/325 mg
PRN (whenever needed) dose. R1 stated that R1 did not received any of the three doses of Pregabalin 200
mg on Saturday (8/16/2025) and Sunday (8/17/2025). R1 stated, I couldn't take it. Every time I tried to
move, the pain really hurt, and it continued. It didn't slow down. R1 stated that on 8/18/25, R1 did not
receive the 9:00 AM or 1:00 PM doses of the Pregabalin 200 mg, and R1 finally received the Pregabalin
200 mg on Monday evening dose on 8/18/2025 (scheduled at 9:00 PM).
R1's Medication Administration Record (MAR), dated August 2025, documents, in part, a medication order
of Pregabalin 100 mg capsules, Give 200 mg by mouth three times a day for Neuropathy, with scheduled
times of 9:00 AM, 1:00 PM, and 9:00 PM. The following documentation for R1's Pregabalin 200 mg is
noted:8/16/2025 for 9:00 AM, 1:00 PM AND 9:00 PM: V8 (LPN, Former Employee) documents a pharmacy
code of 9 which indicates Other / See Nurse Notes.8/17/2025 for 9:00 AM and 1:00 PM: V4 (LPN)
documents a pharmacy code of 9 which indicates Other / See Nurse Notes.8/17/2025 for 9:00 PM: V5
(Registered Nurse, RN) documents a pharmacy code of 9 which indicates Other / See Nurse
Notes.8/18/2025 for 9:00 AM and 1:00 PM: V4 (LPN) documents a pharmacy code of 9 which indicates
Other / See Nurse Notes.
R1's eMAR Progress Notes document, in part, the following correlating documentation for R1's Pregabalin
200 mg from the August 2025 eMAR:8/16/2025: No eMAR Medication Administration Nurses Notes from
V8 (LPN, Former Employee) for Pregabalin 200 mg scheduled 9:00 AM, 1:00 PM AND 9:00 PM.8/17/2025
at 9:24 AM: V4 (LPN) documents an eMAR Medication Administration Nurses Note for Pregabalin of
Awaiting pharmacy delivery. There is no eMAR Medication Administration Nurses Note from V4 for the
Pregabalin 200 mg scheduled at 1:00 PM.8/17/2025 at 10:37 PM: V5 (RN) documents an eMAR
Medication Administration Nurses Note for Pregabalin of Awaiting pharmacy delivery.8/18/2025 at 9:19 AM
and 2:42 PM, V4 (LPN) documents eMAR Medication Administration Nurses Notes for Pregabalin of
Awaiting pharmacy delivery for the Pregabalin 200 mg scheduled doses of 9:00 AM and 1:00 PM.
R1's eMAR, dated August 2025, documents, in part, a medication order of Hydrocodone-Acetaminophen
5-325 mg, Give 1 tablet by mouth every 8 hours as needed (PRN) for pain. The documentation for R1's
Hydrocodone-Acetaminophen 5-325 mg PRN is documented, in part, as follows:8/15/2025 at 11:01 PM:
V14 (LPN) documents administration with R1's pain scale as 3 on a 0 to 10.8/17/2025 at 8:00 AM: V4
(LPN) documents administration with R1's pain scale as 5 on a 0 to 10.
On 8/20/2025 at 2:33 PM, V4 (LPN) stated that on 8/13/2025, V9 (LPN) informed V4 to follow up with trying
to get a new prescription for R1's Pregabalin 200 mg due to the low amount of capsules remaining for R1.
V4 stated that when the pharmacy multidose blister pack (which stores each Pregabalin capsule in
numbered blister pouches on a card) is around 8 to 10 capsules remaining, V4 will start the process of
obtaining replacement medications, so the resident does not run out of Pregabalin. V4 stated that V4 called
the doctor's office for V11 (Attending Physician) and left a message for the need for R1's new Pregabalin
prescription with unknown office staff. V4 stated that on Friday, 8/15/2025, R1's Pregabalin supply (amount
of capsules remaining in the controlled substance box) was due to be used completely on 8/15/2025, and
when V4 called the pharmacy, V4 was informed that there was no prescription for Pregabalin 200 mg to
send the new supply. V4 stated that on 8/17/2025, when V4 started V4's day shift, R1 was complaining of
pain, and V4 medicated R1 with Hydrocodone-Acetaminophen 5-325 mg PRN. V4 stated that on 8/17/2025,
R1's Pregabalin 200 mg capsules were not present in the facility, and R1 did not receive the scheduled
9:00 AM and 1:00 PM doses on V4's shift. V4 stated that on 8/17/2025, V4 stated that V4 phoned V10 and
the physical medicine doctor about R1 not having the Pregabalin in the facility. When asked if V4
documented
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145343
If continuation sheet
Page 3 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145343
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/21/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Ambassador Nursing & Rehab Center
4900 North Bernard
Chicago, IL 60625
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Actual harm
these physician notifications, V4 stated that V4 only made an eMAR note. V4 stated that on 8/18/2025, R1
still did not have the Pregabalin in the facility to administer to R1 at 9:00 AM and 1:00 PM. V4 stated that V4
phoned the pharmacy at the end of V4's shift on 8/18/2025, and V4 was informed that the Pregabalin for R1
was being delivered on 8/18/2025.
Residents Affected - Few
On 8/21/2025 at 2:02 PM, V14 (LPN) stated that V14 was the evening shift (3-11PM) for R1 on 8/15/2025.
V14 stated that V14 had received in nursing report from V4 (LPN) that they were expecting the Pregabalin
from pharmacy. V14 stated that V14 either called R1's primary doctor (V11) or the on-call doctor's service
to obtain more Pregabalin for R1 but couldn't remember exactly which one, and V14 did not receive a return
doctor's phone call. V14 stated that V14 did not document the doctor phone call on 8/15/2025. V14 stated
that for R1's Pregabalin 200 mg scheduled dose on 8/15/2025 at 9:00 PM, R1 had the last dose given
which was 1 capsule. When informed that R1's Pregabalin order was for Pregabalin 100 mg and to give 2
capsules for the 200 mg dose, V14 stated that V14 is pretty sure that the one Pregabalin capsule was a 200
mg dose. V14 stated that R1 complained of pain to R1's legs around 11:00 PM on 8/15/2025, and V14
medicated R1 with a Hydrocodone-Acetaminophen 5-325 mg PRN dose.
On 8/20/2025 at 6:11 PM, V8 (LPN, Former Employee) stated that V8's last day of employment at the
facility was 8/16/2025. V8 stated that R1 is alert, oriented, needs ADL help due to paraplegia and has pain
in R1's legs which radiates down R1's legs. V8 stated that on 8/16/2025, V8 was R1's nurse for the day and
evening shifts (7 AM to 11 PM). V8 stated that R1's Pregabalin 200 mg capsules were not in the controlled
substance box in the medication cart. V8 stated that on 8/16/2025, V8 called the pharmacy, and they said
that they needed a prescription for the Pregabalin. When asked if V8 notified R1's doctor about R1 not
receiving R1's scheduled 9 AM/1PM/9PM doses on 8/16/2025, V8 stated that V8 could not remember if V8
called a doctor; if V8 spoke over the phone or via text for a doctor; or if V8 left a voicemail message for a
doctor about R1's missing Pregabalin doses. When asked if V8 documents when V8 notifies a doctor of a
resident missing a scheduled pain medication, V8 said that V8 would put a note in the electronic health
record (EHR) generated from the eMAR. (Review of R1's eMAR Medication Administration Nurses Notes
for Pregabalin documentation on 8/16/2025 shows no eMAR Medication Administration Nurses Notes on
8/16/2025).
On 8/20/2025 at 2:44 PM, V5 (RN) stated that on 8/17/2025, V5 worked the evening shift (3-11PM) and
was R1's nurse. V5 stated that V5 did not administer R1's scheduled 9:00 PM dose of Pregabalin 200 mg
due to the medication not available in the facility to administer. V5 stated that on 8/17/2025, V4 had
reported in nursing report to V5 that V4 had already called the pharmacy and doctor about R1's Pregabalin.
V5 stated that V5 did not make a call to R1's doctors about R1 missing R1's scheduled 9:00 PM dose of
Pregabalin.
On 8/20/2025 at 3:17 PM, V7 (Assistant Director of Nursing, ADON) stated that when V7 returned back to
work on Monday, 8/18/25, V7 was informed by the Resident Council President that R1 wanted to speak to
V7. V7 stated that V7 immediately went to see R1 who informed V7 that R1 did not have or receive
Pregabalin over the weekend (8/16//2025 to 8/17/2025) and no doses of Pregabalin as of their conversation
on 8/18/2025. V7 stated that Pregabalin is used specifically for neurological pain and is a controlled
substance (requiring a prescription). V7 stated that Hydrocodone/Acetaminophen is a narcotic medication
for generalized pain and also requires a prescription. V8 stated that from the clinical standpoint,
(Pregabalin) is more effective for neurological pain. V7 stated that it's the nurse's job description and is the
expectation that if a medication is not available in the facility to be administered, the nurse must call the
doctor to notify the doctor. V7 stated that controlled substances that need a prescription, the nurse is
expected to not wait until the medication runs out to call the doctor or call the pharmacy. V7 stated that it's
the nurse's responsibility to continue to
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145343
If continuation sheet
Page 4 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145343
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/21/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Ambassador Nursing & Rehab Center
4900 North Bernard
Chicago, IL 60625
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Actual harm
Residents Affected - Few
call the doctor or nurse practitioner if the nurse does not receive a timely response from the initial call
placed. V8 stated, It's not acceptable to leave a message with doctor on an answering service and not
follow up. V7 stated that there has to be effective communication for continuity of care. V7 stated that there
used to be an on-site nurse practitioner (V12) in the facility every Monday through Friday from 9:00 AM to
4:00 PM who would write the prescription refills for a resident's controlled substance medication that was
due to be empty (zero remaining) over the weekend; therefore, there would be no lapse in medication
coverage. V7 stated that V12 stopped working in the facility within the past 1 to 2 weeks while V7 was off of
work. V7 stated that the if the nurse does not receive a return call back from a doctor or nurse practitioner,
the nurse should call the medical director of the facility, V13. V7 stated that with R1 not receiving the
scheduled Pregabalin three times a day for 2 and 1/2 days, R1 would be in excruciating pain, discomfort
and stress and this would affect R1's mood, where R1 would not be a happy client.
On 8/20/25 at 4:19 PM, V2 (DON) stated that Pregabalin is a controlled substance that requires a
prescription from the doctor for pharmacy to refill this medication. V2 stated that nurses are expected to
notify a resident's physician or nurse practitioner for renewal of Pregabalin prior to the medication being
completely administered (zero capsules remaining). V2 stated that V12 (Former Nurse Practitioner) stopped
working in the facility 2 weeks ago, and nurses are expected to follow up with the primary doctors/nurse
practitioners for medication refills. V2 stated that V15 (Nurse Practitioner) is now managing some residents,
including R1, for pain management needs. When asked about V2 being notified or was V2 aware of R1's
Pregabalin not being administered as scheduled, V2 stated that V2 worked 4 hours in the facility on
8/15/2025 and was not answering or taking work phone calls over the weekend (8/16-8/17/2025) adding, I
(V2) was [NAME] (missing in action). V2 stated that when a nurse goes to administer a medication to a
resident and the medication is not available in the facility, the nurse will document a pharmacy code of 9
and will document the reason why the medication was not administered. V2 stated that the nurse is to notify
the doctor also of the resident missing a scheduled medication as ordered by the doctor. V2 stated, They
(nurses) should be documenting the doctor when they notify them (doctors).
On 8/21/2025 at 12:50 PM, V15 (Nurse Practitioner) stated that V15 is the physical medicine nurse
practitioner seeing several residents, including R1, in the facility for pain management and evaluates
frequency needs for narcotic medications. V15 stated that V15 visited R1 on 8/18/25 and that R1 has
paraplegia. V15 stated that R1 has used Hydrocodone-Acetaminophen sparingly (1 to 2 times) and that
nurses verified this as well. V15 stated that R1 is on scheduled medications for R1's pain, such as
Pregabalin, and Pregabalin has an indicated use for neuropathic or polyneuropathy pain. V15 stated that
narcotics, like Hydrocodone-Acetaminophen, that are not needed long-term, should be weaned off,
especially if the resident's pain is controlled by other medications. When asked the potential of R1 not
receiving scheduled Pregabalin as ordered, what are potential risks that R1 can experience, and V15
stated that R1's pain would increase and not be controlled. When asked how many days can a resident be
without pain, or experiencing pain, when the resident is not receiving their scheduled doses of Pregabalin,
V15 stated that V15 cannot give an exact time frame, but Pregabalin is a medication that needs to build up
in the system, and we don't want a lapse in giving this medication in my professional opinion.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145343
If continuation sheet
Page 5 of 5